Category Archives: leadership

Trust Issues: Dealing with Academia

By Ben Comer | Published: April 11, 2012

Worried they might get taken for a ride, university tech transfer offices are beginning to hire ex-pharma and biotech personnel to help negotiate deals with industry. On exiting a theater, writers are often astounded and dismayed by the film resulting from a screenplay they’ve sold to a producer. Punch-up writers have added corny jokes, directors have [...]

Also posted in Biotech, Deals, IP, R&D, Strategy, Technology | Tagged academia, collaboration, Deals, partnerships, technology transfer | 1 Comment

Highlights from the Leerink Swann Healthcare Conference

By Ben Comer | Published: March 13, 2012

Over a hundred public companies, dozens of clinicians, and several regulators participated in investment firm Leerink Swann’s 2012 Healthcare Conference in mid-February. Press was barred from the event, but John Sullivan, Leerink’s director of research, gives PharmExec a few of the take-aways.

Also posted in Biotech, Events, FDA, Gene therapy, Strategy, Technology | Tagged CDER, companion diagnostics, conference, DNA, FDA, genetics, Janet Woodcock, Leerink Swann, Next Generation Sequencing | Leave a comment

Missed Opportunities in Advanced Data Analytics

By Ben Comer | Published: March 6, 2012

SAS’s Brad Sitler talks about the importance of incremental sales, customer proximity, and anticipating a compensation model based on health outcomes

Also posted in Advertising, Marketing, healthcare | Tagged analytics, branded pharma, Data, SaS | Leave a comment

Rare Disease Day: Spotlight on Solidarity

By Jennifer Ringler | Published: February 28, 2012

Patients, policymakers and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities. Aligning humanistic objectives with business incentives is often the sine qua non of effective community activism. This year’s Rare Disease Day – hosted in the US by the National [...]

Also posted in Events, FDA, Global, Patient Communication, Strategy, healthcare, patient education, social media | Tagged FDA, NIH, NORD, orphan diseases, patient groups, patient information, Rare Disease Day, rare diseases | Leave a comment

Genentech Runs Voluntary Corrective Ads for Boniva

By Ben Comer | Published: January 18, 2012

Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.

Also posted in Advertising, Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance | Tagged DDMAC, Genentech, OPDP, Roche | Leave a comment